Bone marrow augmentation in kidney transplantation: A large animal study

Transplant International

Volumn 14, Issue 3, 2001, Pages 159-169

  Gruessner, R W G ^a   Zhang, Kristine Y ^a   Dunning, Michele ^a   Nakhleh, Raouf E ^a   Gruessner, Angelika C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow augmentation; Donor cell augmentation; Kidney transplantation

Indexed keywords

PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; MIXED LYMPHOCYTE CULTURE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWINE; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DRUG ADMINISTRATION SCHEDULE; GRAFT REJECTION; GRAFT VS HOST DISEASE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; SWINE; TACROLIMUS; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 0034924023     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470100318     Document Type: Article

References (36)

1. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients
2. Actively acquired tolerance of foreign cells
3. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody: Evidence of a clear role for short-term antigen persistence
4. Analysis of graft and patient survival in recipients of donor-specific bone marrow with immunosuppressive therapy - A final report of 85 patients
5. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation
6. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients
7. Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells
8. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients
9. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients
10. Rejection in single versus combined pancreas and kidney transplantation in pigs
11. Quadruple immunosuppression in a pig model of small bowel transplantation
12. Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation
13. Effect of timing of bone marrow injection on the prolongation of skin grafts in ALS-treated mice
14. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
15. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed alogeneic chimeras (B10 + B10.D2 -B10)
16. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells
17. The human bone marrow as an immunoregulatory organ
18. Use of donor-specific bone marrow to facilitate tolerance in clinical solid organ transplantation: Old facts and future prospects
19. Studies on heterologous antilymphocyte serum in mice. III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum
20. Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: Case report of an initial attempt
21. Attempt to induce unresponsiveness to human renal allografts with antilymphocyte globulin and donor-specific bone marrow
22. Post-transplantation donor-specific bone marrow transfusion in polyclonal antilymphocyte serum-treated recipients: The optimal cellular antigen for induction of unresponsiveness to organ allografts
23. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats
24. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients
25. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model
26. Donor-type microchimerism associated with graft rejection eight years after liver transplantation
27. Combined simultaneous kidney/bone marrow transplantation
28. Peripheral blood microchimerism in human liver and renal transplant recipients
29. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts
30. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end-stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism
31. Cell migration, chimerism, and graft acceptance
32. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation
33. Promotion of incompatible allograft acceptance in rhesus monkeys given post-transplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting microchimerism
34. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs
35. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia
36. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: Dose and timing